[7] The Ozempic Summary of Product Characteristics (SmPC) includes warnings about pancreatitis, advising caution in patients with a history of pancreatitis and stating that semaglutide should not be restarted if pancreatitis is confirmed
This review has significant implications for the management of T2D, making it a compelling read for healthcare professionals, researchers, and clinicians
It also contains probiotics which support gut health
On October 5, 2023, an important study, published in JAMA and authored by Mohit Sodhi, indicated an increased risk of gastroparesis, bowel obstruction, and pancreatitis for those using GLP-1 agonists
Nausea can occur because the medication affects the digestive system, slowing gastric emptying and altering hunger signals